Stock Markets July 10, 2026 04:20 AM

Bulten to Sell European Manufacturing Arm to Maelir; Shares Rally

Deal values contract manufacturing operations at about €44.5m excl. leasing debt, reshaping Bulten’s business mix and triggering a large impairment

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn

Bulten AB has signed a binding agreement to sell its European automotive contract manufacturing businesses to Swedish investment firm Maelir AB for an enterprise value of approximately 44.5 million euros, excluding leasing debt. The transaction, covering operations in four countries and roughly 1,000 employees, is expected to close by October 2026 pending regulatory approval and will materially reduce Bulten’s reported net sales while shifting the company toward higher-value, less capital-intensive activities.

Bulten to Sell European Manufacturing Arm to Maelir; Shares Rally
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Binding agreement to sell European automotive contract manufacturing operations to Maelir AB for an enterprise value of about 44.5 million euros, excluding leasing debt.
  • Total consideration expected to be approximately 273 million Swedish kronor after adjustments - about 41 million kronor in cash at completion and 232 million kronor via a secured vendor note.
  • Transaction covers operations in Sweden, Romania, Germany and Poland, involves roughly 1,000 employees, and would lower Bulten’s annual net sales by about 1.9 billion kronor (circa 38% of group net sales) based on 2025 figures.

Bulten AB announced a binding agreement to divest its European automotive contract manufacturing operations to Swedish investor Maelir AB for an enterprise value of roughly 44.5 million euros, excluding leasing debt. The deal, disclosed on Monday, triggered a notable uptick in the company’s share price as investors reacted to the strategic move.

Under the terms presented by Bulten, the total consideration is estimated at about 273 million Swedish kronor after standard adjustments for cash, debt, working capital and other items. At closing, approximately 41 million kronor is expected to be paid in cash, while the balance - around 232 million kronor - will be provided via a secured vendor note.

The divested operations span facilities in Sweden, Romania, Germany and Poland and involve roughly 1,000 employees. Based on Bulten’s reported figures for 2025, the sale would reduce the company’s annual net sales by about 1.9 billion kronor, which corresponds to roughly 38% of group net sales.

Bulten’s management framed the transaction as a continuation of a strategic review announced on June 23, 2025. The company expects the sale to complete no later than October 2026, subject to receipt of necessary regulatory approvals. From the second quarter of 2026, the business targeted for divestment will be classified as assets held for sale.

Following completion, brand rights for the divested business will transfer to Maelir AB. Bulten will retain the right to use the brand for up to 24 months after closing. The company will also keep its full-service provider operations in the United Kingdom and will concentrate on a narrower portfolio with greater emphasis on C-Parts management, sourcing, distribution and precision manufacturing.

Management flagged a sizable accounting impact from the strategic reshaping. Bulten expects to record a total write-down of approximately 1.06 billion kronor tied to this transaction as well as previously announced divestments in China and the United States. Despite that anticipated impairment, the company indicated the transaction is expected to be accretive to earnings per share on a pro forma basis.

Executives described the move as a step toward creating a less capital-intensive group with a higher share of value-added activities, and a clearer foundation for profitable growth. The precise timetable for regulatory clearance and the operational transition will determine the ultimate timing and cash flow profile of the transaction.


Summary

Bulten has reached a binding agreement to sell its European contract manufacturing operations to Maelir for an enterprise value of about 44.5 million euros, excluding leasing debt. The sale is expected to reduce group net sales by roughly 1.9 billion kronor and involves around 1,000 employees across four countries. Consideration is expected to total about 273 million kronor, delivered as approximately 41 million kronor in cash and a secured vendor note of roughly 232 million kronor. The deal is subject to regulatory approval and is expected to close by October 2026.

Risks

  • Regulatory approvals are required for the transaction to close, creating timing and execution uncertainty - impacts legal and corporate governance sectors.
  • The company expects a total write-down of about 1.06 billion kronor related to this and other divestitures, which poses balance-sheet and earnings volatility risk - affects financial and investor relations sectors.
  • Reduction of nearly 38% of group net sales and the transfer of operations involving approximately 1,000 employees create operational and scale-related risks during the transition - impacts manufacturing and labor markets.

More from Stock Markets

Berenberg Downgrades Troax, Cites Prolonged Margin Recovery Amid Auto Weakness Jul 10, 2026 Melexis Shares Drop After Deutsche Bank Switches to Hold Despite Higher Target Jul 10, 2026 Bulten Shares Jump After Q2 2026 Profit Improvement and Deal to Sell European Manufacturing Arm Jul 10, 2026 Bayer, Apollo Finalize €3 Billion Equity Financing for Contraceptives Unit Jul 10, 2026 Fielmann Shares Drop After Tepid H1 Results and Guidance Trim Jul 10, 2026